Salivary Drug Concentration Exploratory Study of Cetylpyridinium Chloride Buccal Tablets
Status:
Not yet recruiting
Trial end date:
2023-04-30
Target enrollment:
Participant gender:
Summary
The study is a single-arm, open-label study to explore the salivary concentration of
Cetylpyridinium Chloride Buccal Tablets after single-dose administration in Healthy Subjects